Disordered Tissue Biomechanics as a Driver of Esophageal Disease
Project Number5P01DK117824-04
Contact PI/Project LeaderPANDOLFINO, JOHN E
Awardee OrganizationNORTHWESTERN UNIVERSITY AT CHICAGO
Description
Abstract Text
PROJECT SUMMARY
Esophageal diseases are extremely common with over a million outpatient clinic visits for dysphagia a year, 20%
of the population suffering with gastroesophageal reflux disease and approximately 50,000 emergent
endoscopies being performed a year for food impactions. Symptoms focused on dysphagia, chest pain,
regurgitation and fear of choking dramatically impact quality of life and aspiration and malnutrition are associated
with significant mortality. Central to esophageal disease pathogenesis is abnormal bolus transport and this
function is dependent on a delicate mechanical interplay as the esophagus must accommodate a large volume
in a short time and propel the bolus down the esophagus in a low-pressure state. Given this delicate balance,
even small changes in esophageal wall distensibility can have dramatic effects on bolus transport and the
strain/stress relationship of the esophageal wall. To date, there has been very little investigation into these
important mechanical processes as most of the emphasis has been on peristalsis and contractile vigor. Using
novel techniques developed in our lab focused on high-resolution impedance, our team has been able to show
that the mechanical properties of the esophageal wall and the response to volume distention are important in
esophageal disease pathogenesis. Using the functional lumen imaging probe (FLIP) and refining this technique
into FLIP-panometry, we were able to determine new metrics that define wall distensibility in eosinophilic
esophagitis, achalasia and non-obstructive dysphagia. Additionally, we defined a new motor pattern that was
directly stimulated by distention and likely represents a secondary peristaltic like response in the form of repetitive
antegrade contractions (RACs). Further work focused on RACs support that this response has important
functional and clinical relevance in esophageal acid clearance and bolus transport in dysphagia. Given this
preliminary data, we have developed a program project grant (PPG) focused on “Disordered Tissue
Biomechanics as a Driver of Esophageal Diseases”. In order to fully understand this pathogenic mechanism,
we have brought together a group of investigators with varying expertise to develop a comprehensive model of
disease activity using a 4 pronged attack. Project 1 will determine the triggers and molecular mechanisms behind
abnormal wall distensibility and Project 2 will study the effect of esophageal wall distensibility on altering the
response to volumetric distention focused on its effect on bolus transport. Project 3 will utilize direct measures
of tissue material properties and physiologic data from Project 2 to develop in-silico models of esophageal
transport to both test the hypotheses derived in Projects 1 and 2 and reverse engineer hybrid diagnostics that
can determine the actual mechanics behind the abnormal function uncovered by FLIP and manometry. Last,
Project 4 will determine the role of central mediated cognitive processes on symptoms and as an overarching
goal develop a complex model that will incorporate physiologic biomarkers, measures of mechanical properties
of the esophageal wall with psychological mediators of symptom generation.
Public Health Relevance Statement
PROJECT NARRATIVE
Esophageal disease is associated with a significant reduction in quality of life that is directly related to
symptoms of dysphagia, chest pain, regurgitation, and choking. There is also secondary morbidity and
mortality associated with aspiration and malnutrition. This program project grant assembles a team of
investigators from a wide range of disciplines to study how disease states alter the structure and mechanical
properties of the esophagus resulting in compromised function. We will be using animal models of
scleroderma and eosinophilic esophagitis, human physiologic studies, mathematical models, computer
simulations, and psychometric analysis to develop an array of tools aimed at improving the management of
esophageal disease.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
005436803
UEI
KG76WYENL5K1
Project Start Date
15-July-2018
Project End Date
30-June-2023
Budget Start Date
01-July-2021
Budget End Date
30-June-2022
Project Funding Information for 2021
Total Funding
$1,448,086
Direct Costs
$962,499
Indirect Costs
$485,587
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Diabetes and Digestive and Kidney Diseases
$1,448,086
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01DK117824-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01DK117824-04
Patents
No Patents information available for 5P01DK117824-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01DK117824-04
Clinical Studies
No Clinical Studies information available for 5P01DK117824-04
News and More
Related News Releases
No news release information available for 5P01DK117824-04
History
No Historical information available for 5P01DK117824-04
Similar Projects
No Similar Projects information available for 5P01DK117824-04